Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
27,98 USD | +0,59 % | +1,34 % | -0,39 % |
09/04 | ROYALTY PHARMA PLC : Morgan Stanley toujours positif | ZM |
05/03 | Transcript : Royalty Pharma plc Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 10:30 AM |
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Biopharmaceutical Royalties
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01/01/96 |
Terrance Coyne
DFI | Director of Finance/CFO | 42 | 01/01/10 |
Eric Schneider
CTO | Chief Tech/Sci/R&D Officer | - | 21/09/23 |
James Reddoch
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/07/08 |
Arthur McGivern
CIO | Chief Investment Officer | - | 12/10/22 |
Sara Klymkowsky
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/12 |
Brienne Kugler
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/14 |
George Lloyd
CIO | Chief Investment Officer | 64 | 01/01/11 |
Christopher Hite
BRD | Director/Board Member | 57 | 01/03/20 |
George Grofik
IRC | Investor Relations Contact | - | 01/01/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 01/01/96 |
Errol de Souza
BRD | Director/Board Member | 70 | 01/06/20 |
David Hodgson
BRD | Director/Board Member | 67 | 23/06/22 |
Ted Love
BRD | Director/Board Member | 65 | 30/07/20 |
Henry Fernandez
BRD | Director/Board Member | 65 | 30/07/20 |
Gregory Norden
BRD | Director/Board Member | 66 | 11/02/20 |
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01/01/96 |
Mario Giuliani
BRD | Director/Board Member | 52 | 01/06/20 |
Bonnie Bassler
BRD | Director/Board Member | 61 | 16/06/20 |
Christopher Hite
BRD | Director/Board Member | 57 | 01/03/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 50 000 | 0 | 0 | 95,08 % |
Action B | 1 | 150 743 276 | 0 | 0 | |
Action C | 1 | 446 691 515 | 424 704 211 ( 95,08 %) | 0 |
Coordonnées société
Royalty Pharma Plc
110 East 59th Street 33rd floor
10022, New York
+212 883 0200
http://www.royaltypharma.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Royalty Pharma Holdings Ltd.
Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Royalty Pharma Holdings Ltd. operates as an investment holding company. The company was founded on February 10, 2020 and is headquartered in Bristol, the United Kingdom. |
Financial Conglomerates
|
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-0,39 % | 12,5 Md | |
+25,61 % | 660 Md | |
+23,66 % | 562 Md | |
-5,24 % | 358 Md | |
+16,49 % | 322 Md | |
+8,28 % | 297 Md | |
+13,15 % | 219 Md | |
-9,65 % | 196 Md | |
+6,86 % | 199 Md | |
-8,75 % | 149 Md |
- Bourse
- Actions
- Action RPRX
- Société Royalty Pharma plc